Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2006-05-22 15:12:13 UTC |
---|
Update Date | 2022-03-07 02:49:17 UTC |
---|
HMDB ID | HMDB0002835 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Danazol |
---|
Description | Danazol is a synthetic steroid with anti-oestrogenic and anti progestogenic activity, and weak androgenic properties. Danazol suppresses oestrogen and progesterone receptors in the endometrium, leading to endometrial atrophy (thinning of the lining of the uterus) and reduced menstrual loss and to amenorrhoea in some women. Danazol significantly lowers the duration of menses when compared with NSAIDs and a progesterone releasing IUD; however, caused more adverse events than NSAIDs and progestogens. The use of Danazol may be limited by its side effect profile, its acceptability to women and the need for continuing treatment. Because danazol is structurally related to the anabolic steroid stanozolol, its use should be questioned. Derivatization methods and GC/MS data are used to implement danazol detection in routine screening and confirmation procedures in doping analysis. Danazol main metabolite ethisterone is excreted relatively fast in urine. (PMID: 17636649 , 1640693 , 16288903 ). |
---|
Structure | [H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3 InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1 |
---|
Synonyms | Value | Source |
---|
Cyclomen | ChEBI | Danazolum | ChEBI | Danocrine | ChEBI | (17a)-Pregna-2,4-dien-20-yno[2,3-D]isoxazol-17-ol | HMDB | 1-Ethynyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-10a,12a-dimethyl-1H-cyclopenta[7,8]phenanthro[3,2-D]isoxazol-1-ol | HMDB | 17 alpha-Pregna-2,4-dien-20-yno[2,3-D] isoxazol-17 beta-ol | HMDB | 17a-Pregna-2,4-dien-20-yne-[2,3-D]isoxazole-17b-ol | HMDB | 17a-Pregna-2,4-dien-20-yno[2,3-D]isoxazol-17-ol | HMDB | 1H-Cyclopenta[7,8]phenanthro[3,2-D]isoxazole- pregna-2,4-dien-20-yno[2,3-D]isoxazol-17-ol deriv. | HMDB | Bonzol | HMDB | Chronogyn | HMDB | Danol | HMDB | Danovaol | HMDB | Danzol | HMDB | Ladogal | HMDB | Winobanin | HMDB | Alphapharm brand OF danazol | HMDB | Kendrick brand OF danazol | HMDB | Sanofi brand OF danazol | HMDB | Danatrol | HMDB | Danazant | HMDB | Danazol-ratiopharm | HMDB | Danoval | HMDB | Ratiopharm brand OF danazol | HMDB | Antigen brand OF danazol | HMDB | Azol | HMDB | Norciden | HMDB | Panacrine | HMDB | Sanofi synthelabo brand OF danazol | HMDB | Sanofi winthrop brand OF danazol | HMDB | Danazol ratiopharm | HMDB |
|
---|
Chemical Formula | C22H27NO2 |
---|
Average Molecular Weight | 337.4553 |
---|
Monoisotopic Molecular Weight | 337.204179113 |
---|
IUPAC Name | (1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.0^{2,10}.0^{4,8}.0^{14,18}]icosa-4(8),5,9-trien-17-ol |
---|
Traditional Name | (1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.0^{2,10}.0^{4,8}.0^{14,18}]icosa-4(8),5,9-trien-17-ol |
---|
CAS Registry Number | 17230-88-5 |
---|
SMILES | [H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3 |
---|
InChI Identifier | InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1 |
---|
InChI Key | POZRVZJJTULAOH-LHZXLZLDSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as estrane steroids. These are steroids with a structure based on the estrane skeleton. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Estrane steroids |
---|
Direct Parent | Estrane steroids |
---|
Alternative Parents | |
---|
Substituents | - Estrane-skeleton
- Hydroxysteroid
- 17-hydroxysteroid
- Ynone
- Heteroaromatic compound
- Azole
- Cyclic alcohol
- Tertiary alcohol
- Isoxazole
- Acetylide
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Hydrocarbon derivative
- Organonitrogen compound
- Organooxygen compound
- Organic oxygen compound
- Organic nitrogen compound
- Alcohol
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 225.6 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | 4.081 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.81 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 19.0476 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.41 minutes | 32390414 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2590.0 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 556.2 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 232.9 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 242.3 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 490.3 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 844.4 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 995.1 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 106.4 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1571.8 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 493.2 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1667.5 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 581.5 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 488.5 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 428.3 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 702.7 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Danazol GC-MS (Non-derivatized) - 70eV, Positive | splash10-0ab9-0669000000-7afc135d5b1e92134191 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Danazol GC-MS (1 TMS) - 70eV, Positive | splash10-000x-2479000000-d5f94bb7e7215a30f820 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Danazol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Danazol Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-000i-0009000000-9e745b8feecd354f6618 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Danazol Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-01b9-6902000000-854476472755ef5419e5 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Danazol Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0006-9100000000-0d62c0c1b53c1cea5a25 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Danazol , positive-QTOF | splash10-000i-0329000000-56adc37fd83dfa3c686f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Danazol , positive-QTOF | splash10-05ia-3931000000-1490f6c4984a84016076 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Danazol 90V, Positive-QTOF | splash10-002f-6900000000-529d2d24864b26fdd611 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Danazol 90V, Positive-QTOF | splash10-002f-6900000000-01f21f6ea357e6649d15 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Danazol 30V, Positive-QTOF | splash10-000i-1309000000-271d4ce8113e1bf16016 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Danazol 45V, Positive-QTOF | splash10-00dj-2910000000-3af637f5ddbf8cfd6b84 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Danazol 45V, Positive-QTOF | splash10-00dj-2920000000-ba6bb4b948be2171d864 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Danazol 60V, Positive-QTOF | splash10-05tg-3900000000-29df3c1f08b04956955d | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Danazol 15V, Positive-QTOF | splash10-000i-0009000000-5fc69729a45a40e94073 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Danazol 75V, Positive-QTOF | splash10-002f-4900000000-7ba349192301fd4e5013 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Danazol 60V, Positive-QTOF | splash10-05tg-3900000000-a692616aee182eeb1270 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Danazol 10V, Positive-QTOF | splash10-000i-0119000000-d7acb78e38c02e285d4f | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Danazol 20V, Positive-QTOF | splash10-01wr-0289000000-2db311b410937e72f25a | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Danazol 40V, Positive-QTOF | splash10-000j-3690000000-5eb98df42b0016f9967a | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Danazol 10V, Negative-QTOF | splash10-000i-0009000000-d1a89ea3e6c72ff1ab88 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Danazol 20V, Negative-QTOF | splash10-000i-0009000000-71fbd4000b06296a8386 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Danazol 40V, Negative-QTOF | splash10-00e9-2089000000-24b6d7f3ec074a6c2b59 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Danazol 10V, Positive-QTOF | splash10-000i-0019000000-2626c30d979a970252f0 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Danazol 20V, Positive-QTOF | splash10-007y-0982000000-4cf29ec44560862d68c7 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Danazol 40V, Positive-QTOF | splash10-1001-1890000000-24565065bfdf6e8edf39 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Danazol 10V, Negative-QTOF | splash10-000i-0009000000-8413c28ca2b1374741c7 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Danazol 20V, Negative-QTOF | splash10-000i-0009000000-3424fea43411af836104 | 2021-09-24 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, 100%_DMSO, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|